| For: | Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008; 14(24): 3781-3791 [PMID: 18609700 DOI: 10.3748/wjg.14.3781] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3781.htm |
| Number | Citing Articles |
| 1 |
Manoj Thapa, Dana Tedesco, Sanjeev Gumber, Elizabeth J Elrod, Jin-Hwan Han, William H Kitchens, Joseph F Magliocca, Andrew B Adams, Arash Grakoui. Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. The Journal of Immunology 2020; 204(12) doi: 10.4049/jimmunol.1900391
|
| 2 |
Marco Vincenzo Lenti, Carlo Maria Rossi, Federica Melazzini, Matteo Gastaldi, Serena Bugatti, Mario Rotondi, Paola Ilaria Bianchi, Antonella Gentile, Luca Chiovato, Carlomaurizio Montecucco, Gino Roberto Corazza, Antonio Di Sabatino. Seronegative autoimmune diseases: A challenging diagnosis. Autoimmunity Reviews 2022; 21(9) doi: 10.1016/j.autrev.2022.103143
|
| 3 |
D. Robert Dufour. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 2012; doi: 10.1016/B978-1-4160-6164-9.00050-0
|
| 4 |
Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin. Mechanisms of tissue injury in autoimmune liver diseases. Seminars in Immunopathology 2014; 36(5) doi: 10.1007/s00281-014-0439-3
|
| 5 |
David Tornai, Peter Laszlo Ven, Peter Laszlo Lakatos, Maria Papp. Serological biomarkers for management of primary sclerosing cholangitis. World Journal of Gastroenterology 2022; 28(21): 2291-2301 doi: 10.3748/wjg.v28.i21.2291
|
| 6 |
|
| 7 |
Pan Luo, Lin Liu, Weikun Hou, Ke Xu, Peng Xu, Nadeem Sheikh. Gene Set Enrichment Analysis Detected Immune Cell‐Related Pathways Associated with Primary Sclerosing Cholangitis. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/2371347
|
| 8 |
S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Zeitschrift für Gastroenterologie 2025; 63(06) doi: 10.1055/a-2558-5204
|
| 9 |
Matteo Bramuzzo, Stefano Martelossi, Giuliano Torre, Sabrina Cardile, Serena Arrigo, Silvia Vignola, Federica Ferrari, Giovanna Zuin, Maria Teresa Illiceto, Marco Gasparetto, Salvatore Pellegrino, Claudio Romano, Giuseppe Maggiore, Marcella Montico, Marina Aloi. Clinical Features and Risk Factors of Autoimmune Liver Involvement in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2) doi: 10.1097/MPG.0000000000001078
|
| 10 |
Dermot Gleeson, Rosemary Bornand, Ann Brownlee, Harpreet Dhaliwal, Jessica K Dyson, Janeane Hails, Paul Henderson, Deirdre Kelly, George F Mells, Rosa Miquel, Ye H Oo, Anthea Sutton, Andrew Yeoman, Michael A Heneghan. British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis. Gut 2025; 74(9) doi: 10.1136/gutjnl-2024-333171
|
| 11 |
Vincenzo Ronca, Maria-Carlota Londoño. Primary sclerosing cholangitis pathogenesis revisited: EBV-idence of immune dysregulation. JHEP Reports 2026; 8(3) doi: 10.1016/j.jhepr.2025.101665
|
| 12 |
Alpha Boubacar Conte, Fatoumata Coulibaly, Sofia Jayi, Fatima Zohra Fdili Alaoui, Hikmat Chaara, Moulay Abdelilah Melhouf. Primary sclerosing cholangitis revealed by pregnancy. Obstetrics & Gynecology International Journal 2023; 14(2) doi: 10.15406/ogij.2023.14.00695
|
| 13 |
Ida Schregel, Silja Steinmann, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 2). Gastroenterologie up2date 2022; 18(03) doi: 10.1055/a-1922-9264
|
| 14 |
Kirsten Muri Boberg, Roger W. Chapman, Gideon M. Hirschfield, Ansgar W. Lohse, Michael P. Manns, Erik Schrumpf. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. Journal of Hepatology 2011; 54(2) doi: 10.1016/j.jhep.2010.09.002
|
| 15 |
A. Schreiber, B. Rudolph, A. Kahl, R. Kettritz. Akutes Nierenversagen bei einem lebertransplantierten Patienten. Der Nephrologe 2015; 10(5) doi: 10.1007/s11560-014-0932-7
|
| 16 |
Brian K. Chung, Gideon M. Hirschfield. Immunogenetics in primary sclerosing cholangitis. Current Opinion in Gastroenterology 2017; 33(2) doi: 10.1097/MOG.0000000000000336
|
| 17 |
Tom H. Karlsen, Trine Folseraas, Douglas Thorburn, Mette Vesterhus. Primary sclerosing cholangitis – a comprehensive review. Journal of Hepatology 2017; 67(6) doi: 10.1016/j.jhep.2017.07.022
|
| 18 |
Dominik Roth, Miriam M Düll, Ludwig J Horst, Aylin Lindemann, Xenia Malzer, Kristina Koop, Sebastian Zundler, Marcel Vetter, André Jefremow, Raja Atreya, Carol Geppert, Sören Weidemann, Maximilian J Waldner, Peter Dietrich, Claudia Günther, Luis E Munoz, Martin Herrmann, Alexander Scheffold, Markus F Neurath, Jürgen Siebler, Christoph Schramm, Andreas E Kremer, Moritz Leppkes. Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2025; 19(2) doi: 10.1093/ecco-jcc/jjae131
|
| 19 |
Byoung Uk Park, Zongming Eric Chen. Practical Liver Pathology. Practical Anatomic Pathology 2025; doi: 10.1007/978-3-031-97506-6_10
|
| 20 |
Shou-Pei Liu, Zhen-Hua Bian, Zhi-Bin Zhao, Jinjun Wang, Weici Zhang, Patrick S.C. Leung, Liang Li, Zhe-Xiong Lian. Animal Models of Autoimmune Liver Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2020; 58(2) doi: 10.1007/s12016-020-08778-6
|
| 21 |
Elisabeth M.G. de Vries, Ulrich Beuers, Cyriel Y. Ponsioen. Biomarkers for disease progression of primary sclerosing cholangitis. Current Opinion in Gastroenterology 2015; 31(3) doi: 10.1097/MOG.0000000000000163
|
| 22 |
Hiroyuki Isayama, Susumu Tazuma, Norihiro Kokudo, Atsushi Tanaka, Toshio Tsuyuguchi, Takahiro Nakazawa, Kenji Notohara, Suguru Mizuno, Nobuhisa Akamatsu, Masahiro Serikawa, Itaru Naitoh, Yoshiki Hirooka, Toshifumi Wakai, Takao Itoi, Tomoki Ebata, Shinji Okaniwa, Terumi Kamisawa, Hiroki Kawashima, Atsushi Kanno, Keiichi Kubota, Masami Tabata, Michiaki Unno, Hajime Takikawa. Clinical guidelines for primary sclerosing cholangitis 2017. Journal of Gastroenterology 2018; 53(9) doi: 10.1007/s00535-018-1484-9
|
| 23 |
Kayani Kayani, Amber G Bozward, Scott P Davies, Rebecca Jeyaraj, Ayma Asif, Ye H Oo. Encyclopedia of Immunobiology. 2026; doi: 10.1016/B978-0-12-824465-4.00173-3
|
| 24 |
Laura Räisänen, Christopher Burgess, Fariha Balouch, Peter Lewindon. Proximally dominant inflammation at colonoscopy predicts pan-colonic histological remission following oral vancomycin therapy in pediatric ulcerative colitis. Digestive and Liver Disease 2026; 58(8) doi: 10.1016/j.dld.2026.06.001
|
| 25 |
Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel-Anselmino, Reinhild Klein, Andreas E. Kremer, Petra L. Jansen, Michael Melter, Peter Schirmacher, Christoph Schramm, Martina Sterneck, Christian P. Strassburg, Christina Weiler-Normann, Ansgar W. Lohse. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline. Zeitschrift für Gastroenterologie 2026; 64(05) doi: 10.1055/a-2769-2475
|
| 26 |
Takuma Misawa, Jeffrey A. SoRelle, Jin Huk Choi, Tao Yue, Kuan-wen Wang, William McAlpine, Jianhui Wang, Aijie Liu, Koichi Tabeta, Emre E. Turer, Bret Evers, Evan Nair-Gill, Subhajit Poddar, Lijing Su, Feiya Ou, Liyang Yu, Jamie Russell, Sara Ludwig, Xiaoming Zhan, Sara Hildebrand, Xiaohong Li, Miao Tang, Anne R. Murray, Eva Marie Y. Moresco, Bruce Beutler. Mutual inhibition between Prkd2 and Bcl6 controls T follicular helper cell differentiation. Science Immunology 2020; 5(43) doi: 10.1126/sciimmunol.aaz0085
|
| 27 |
Silja Steinmann, Ida Schregel, Christoph Schramm. Autoimmune Lebererkrankungen – ein Update (Teil 1). Gastroenterologie up2date 2022; 18(03) doi: 10.1055/a-1364-8489
|
| 28 |
James P. Stevens, Nitika A. Gupta. Recent Insights into Pediatric Primary Sclerosing Cholangitis. Clinics in Liver Disease 2022; 26(3) doi: 10.1016/j.cld.2022.03.009
|
| 29 |
|
| 30 |
Teresa Da Cunha, Haleh Vaziri, George Y. Wu. Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. Journal of Clinical and Translational Hepatology 2022; 10(3) doi: 10.14218/JCTH.2021.00344
|
| 31 |
Priscila Menezes Ferri, Ana Cristina Simões e Silva, Soraya Luiza Campos Silva, Diego Junior Queiroga de Aquino, Eleonora Druve Tavares Fagundes, Débora Marques de Miranda, Alexandre Rodrigues Ferreira. The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood. Gastroenterology Research and Practice 2016; 2016 doi: 10.1155/2016/3905240
|
| 32 |
A. I. Parfenov, A. V. Kagramanova, O. V. Knyazev. Systemic manifestations of inflammatory bowel diseases. Terapevticheskii arkhiv 2020; 92(2) doi: 10.26442/00403660.2020.02.000535
|
| 33 |
Nina Barner-Rasmussen, Nelli Sjöblom, Johanna Arola, Sonja Boyd, Hannu Kautiainen, Martti Färkkilä. The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score. Scandinavian Journal of Gastroenterology 2023; 58(12) doi: 10.1080/00365521.2023.2233038
|
| 34 |
U. Spengler. Differenzialdiagnose Ikterus. Der Gastroenterologe 2010; 5(4) doi: 10.1007/s11377-009-0390-3
|
| 35 |
Rosanna Villani, Gaetano Serviddio, Carlo Avolio, Tommaso Cassano, Emanuele D’Amico. Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives. Clinical and Experimental Medicine 2023; 23(7) doi: 10.1007/s10238-023-01128-8
|
| 36 |
Paola De Angelis, Renato Tambucci, Erminia Romeo, Francesca Rea, Claudia Caloisi, Tamara Caldaro, Giovanni Federici di Abriola, Francesca Foschia, Filippo Torroni, L. Monti, Luigi Dall'Oglio. Does an isolated benign choledochal stricture hide a PSC?. Journal of Pediatric Surgery 2013; 48(5) doi: 10.1016/j.jpedsurg.2013.02.020
|
| 37 |
Vitantonio GUGLIELMI, Pietro GIORGIO, Vito GUERRA, Anna SONNANTE, Massimo TUTINO, Rossella DONGHIA, Antonio PISANI. Prognostic value of perinuclear antineutrophil cytoplasmic antibodies in subjects with primary sclerosing cholangitis. Minerva Medica 2022; 113(3) doi: 10.23736/S0026-4806.20.06604-5
|
| 38 |
Lena Berglin, Niklas K. Björkström, Annika Bergquist. Primary sclerosing cholangitis is associated with autoreactive IgA antibodies against biliary epithelial cells. Scandinavian Journal of Gastroenterology 2013; 48(6) doi: 10.3109/00365521.2013.786131
|
| 39 |
T. Liwinski, C. Schramm. Primär sklerosierende Cholangitis. Der Internist 2018; 59(6) doi: 10.1007/s00108-018-0428-z
|
| 40 |
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg, Tom H. Karlsen. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver International 2017; 37(3) doi: 10.1111/liv.13238
|
| 41 |
Maria C. SORRENTINO, Teresa CARBONE, Luigi CINQUANTA, Maria G. ALESSIO, Maria INFANTINO, Gaia DELEONARDI, Maria T. TREVISAN, Brunetta PORCELLI, Lucia TERZUOLI, Stefan PLATZGUMMER, Ignazio BRUSCA, Antonio ANTICO, Marilina TAMPOIA, Giampaola PESCE, Danilo VILLALTA, Nicola BIZZARO. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato. La Rivista Italiana della Medicina di Laboratorio 2024; 20(1) doi: 10.23736/S1825-859X.24.00226-3
|
| 42 |
|
| 43 |
Gary L. Norman, Nicola Bizzaro, Danilo Villalta, Diego Vergani, Giorgina Mieli-Vergani, Gideon M. Hirschfield, Michael Mahler. Precision Medicine and Artificial Intelligence. 2021; doi: 10.1016/B978-0-12-820239-5.00012-7
|
| 44 |
Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio, Michele Biagioli, Eleonora Distrutti. Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments. Cells 2024; 13(19) doi: 10.3390/cells13191650
|
| 45 |
Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, Cristina Di Giorgio, Eleonora Distrutti, Angela Zampella, Michele Biagioli. Immunology of bile acids regulated receptors. Progress in Lipid Research 2024; 95 doi: 10.1016/j.plipres.2024.101291
|
| 46 |
Yash R Shah, Natalia Nombera-Aznaran, David Guevara-Lazo, Ernesto Calderon-Martinez, Angad Tiwari, SriLakshmiDevi Kanumilli, Purva Shah, Bhanu Siva Mohan Pinnam, Hassam Ali, Dushyant Singh Dahiya. Liver transplant in primary sclerosing cholangitis: Current trends and future directions. World Journal of Hepatology 2023; 15(8): 939-953 doi: 10.4254/wjh.v15.i8.939
Abstract(1217) |
Core Tip(893) |
Full Article(HTML)(6494)
|
Full Article (PDF)-3580K(464)
|
Full Article with Cover (PDF)-5359K(323)
|
Full Article (Word)-976K(65)
|
Full Article (XML)-272K(235)
|
Audio-1089K(13)
|
Peer-Review Report-222K(194)
|
Answering Reviewers-112K(204)
|
Times Cited (10)
|
Total Visits (9060)
|
Open
|
| 47 |
Rosebella A. Iseme, Mark McEvoy, Brian Kelly, Linda Agnew, Frederick R. Walker, Michael Boyle, John Attia. A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease. Journal of Immunology Research 2018; 2018 doi: 10.1155/2018/9407971
|
| 48 |
Claudia O. Zein. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2013; 17(2) doi: 10.1016/j.cld.2012.11.003
|
| 49 |
Sergey Moiseev, Jan Willem Cohen Tervaert, Yoshihiro Arimura, Dimitrios P. Bogdanos, Elena Csernok, Jan Damoiseaux, Marc Ferrante, Luis Felipe Flores-Suárez, Marvin J. Fritzler, Pietro Invernizzi, David Jayne, J. Charles Jennette, Mark A. Little, Stephen P. McAdoo, Pavel Novikov, Charles D. Pusey, Antonella Radice, Alan D. Salama, Judith A. Savige, Mårten Segelmark, Yehuda Shoenfeld, Renato A. Sinico, Maria-José Sousa, Ulrich Specks, Benjamin Terrier, Athanasios G. Tzioufas, Severine Vermeire, Ming-Hui Zhao, Xavier Bossuyt. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmunity Reviews 2020; 19(9) doi: 10.1016/j.autrev.2020.102618
|
| 50 |
|
| 51 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical Reviews in Allergy & Immunology 2021; 63(2) doi: 10.1007/s12016-021-08888-9
|
| 52 |
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3) doi: 10.1016/j.jaut.2009.12.002
|
| 53 |
Aalam Sohal, Sanya Kayani, Kris V. Kowdley. Primary Sclerosing Cholangitis. Clinics in Liver Disease 2024; 28(1) doi: 10.1016/j.cld.2023.07.005
|
| 54 |
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2) doi: 10.1016/j.jhep.2009.04.009
|
| 55 |
Sarajo Kumar Mohanta, Changjun Yin, Li Peng, Prasad Srikakulapu, Vineela Bontha, Desheng Hu, Falk Weih, Christian Weber, Norbert Gerdes, Andreas J.R. Habenicht. Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse Atherosclerosis. Circulation Research 2014; 114(11) doi: 10.1161/CIRCRESAHA.114.301137
|
| 56 |
Keisuke Kakisaka, Kazuyuki Ishida, Kojiro Kataoka, Yuji Suzuki, Shunichi Yanai, Hidekatsu Kuroda, Tamotsu Sugai, Takayuki Matsumoto, Yasuhiro Takikawa. Reversible sclerosing cholangitis with ulcerative colitis. Pathology International 2016; 66(7) doi: 10.1111/pin.12427
|
| 57 |
Haiyan Zhang, Patrick S.C. Leung, M. Eric Gershwin, Xiong Ma. How the biliary tree maintains immune tolerance?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4) doi: 10.1016/j.bbadis.2017.08.019
|
| 58 |
Zhengyang Miao, Hailin Chen, Yongming Zhou. Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study. Medicine 2024; 103(47) doi: 10.1097/MD.0000000000040542
|
| 59 |
Brian K. Chung, Bardia T. Guevel, Gary M. Reynolds, D.B.R.K. Gupta Udatha, Eva Kristine Klemsdal Henriksen, Zania Stamataki, Gideon M. Hirschfield, Tom Hemming Karlsen, Evaggelia Liaskou. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. Journal of Autoimmunity 2017; 77 doi: 10.1016/j.jaut.2016.10.003
|
| 60 |
K. Wiencke, K.M. Boberg. Current consensus on the management of primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(12) doi: 10.1016/j.clinre.2011.04.007
|
| 61 |
Nora Cazzagon, Olivier Chazouillères. Diseases of the Liver and Biliary Tree. 2021; doi: 10.1007/978-3-030-65908-0_11
|
| 62 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 63 |
Vasiliy Ivanovich Reshetnyak, Alexandra Andreevna Reshetnyak, Igor Veniaminovich Maev. Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives. World Journal of Hepatology 2026; 18(8): 123377 doi: 10.4254/wjh.123377
|
| 64 |
Caterina Maria Gambino, Luisa Agnello, Vincenza Calvaruso, Rosaria Vincenza Giglio, Luigi Capodicasa, Concetta Scazzone, Giuseppina Candore, Fabio Del Ben, Vito Di Marco, Marcello Ciaccio. Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120037
|
| 65 |
Sang-Heum Park, Hoo Rim Song, Sung Won Lee, Tae Hoon Lee. Wouldn't Human Understanding be Necessary to Treat Patients with Pancreaticobiliary Disease More Effectively?. The Korean Journal of Pancreas and Biliary Tract 2018; 23(3) doi: 10.15279/kpba.2018.23.3.89
|
| 66 |
Ziwen Pan, Weijie Zhang. Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-01941-1
|
| 67 |
Muneji Yasuda, Masahiro Shiokawa, Takeshi Kuwada, Yoshihiro Nishikawa, Risa Nakanishi, Ikuhisa Takimoto, Koki Chikugo, Masataka Yokode, Yuya Muramoto, Shimpei Matsumoto, Takeharu Nakamura, Sakiko Ota, Tomoaki Matsumori, Keiko Kuroda, Takahisa Hachiya, Hajime Yamazaki, Norimitsu Uza, Yuzo Kodama, Tsutomu Chiba, Toshio Fujisawa, Atsumasa Komori, Masanori Abe, Izumi Yamaguchi, Fumihiko Matsuda, Hiroyuki Isayama, Atsushi Tanaka, Hiroshi Seno. Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study. Journal of Gastroenterology 2025; 60(1) doi: 10.1007/s00535-024-02169-w
|
| 68 |
Beate Preuß, Amelie Frank, Birgit Terjung, Ulrich Spengler, Christoph Berg, Reinhild Klein. Autoantibodies to beta tubulin in autoimmune liver diseases—Relation to pANCA and clinical relevance. Clinical and Experimental Immunology 2024; 216(2) doi: 10.1093/cei/uxad114
|
| 69 |
Claudiu Marinel Ionele, Adina Turcu-Stiolica, Mihaela Simona Subtirelu, Bogdan Silviu Ungureanu, George Ovidiu Cioroianu, Ion Rogoveanu. A Systematic Review and Meta-Analysis on Metabolic Bone Disease in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine 2022; 11(13) doi: 10.3390/jcm11133807
|
| 70 |
Martin Cornillet, Aiva Lundberg Båve, Dan Sun, Ghada Nouairia, Christina Villard, Aristeidis Grigoriadis, Erik von Seth, Hannes Jansson, María Bueno Álvez, Sofia Bergström, Peter Nilsson, Mathias Uhlén, Fredrik Edfors, Per Stål, Mårten Werner, Nils Nyhlin, Fredrik Rorsman, Johan Vessby, Nilsson Emma, Antonio Molinaro, Annika Bergquist, Stergios Kechagias, Maria Antonella Burza, Lina Lindström, Ernesto Sparrelid, Niklas K. Björkström, Jonas Halfvarson, Annika Bergquist. Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations. JHEP Reports 2026; 8(3) doi: 10.1016/j.jhepr.2025.101719
|
| 71 |
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3) doi: 10.1038/s41575-022-00690-y
|
| 72 |
. 2019; doi: 10.70675/43488c90z3a87z4265z8aeaz1b3e77ed5a3b
|
| 73 |
Evangelos Triantafyllou, Cathrin L. C. Gudd, Lucia A. Possamai. Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management. Nature Reviews Gastroenterology & Hepatology 2025; 22(2) doi: 10.1038/s41575-024-01019-7
|
| 74 |
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0244950
|
| 75 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.004
|
| 76 |
Mohammed Rifat Shaik, Hee Jae Jung, Nishat Anjum Shaik, Jamal Mikdashi. Diseases of the Gallbladder and the Biliary Tree in Systemic Lupus Erythematosus: Review of Clinical Presentation, Diagnosis and Management. Indian Journal of Rheumatology 2025; 20(2) doi: 10.1177/09733698241300754
|
| 77 |
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke, Tom H. Karlsen. Genetics in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 2012; 36(4) doi: 10.1016/j.clinre.2012.02.003
|
| 78 |
Dong Xi, Henry Lin, Amit A. Shah. Overview of autoimmune liver disease: Prevalence, risk factors, and role of autoantibodies. Clinical Liver Disease 2022; 20(4) doi: 10.1002/cld.1227
|
| 79 |
A. V. Nikitin, G. V. Volynets. Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2021; 66(1) doi: 10.21508/1027-4065-2021-66-1-39-46
|
| 80 |
Kai Markus Schneider, Martin Kummen, Palak J. Trivedi, Johannes R. Hov. Role of microbiome in autoimmune liver diseases. Hepatology 2024; 80(4) doi: 10.1097/HEP.0000000000000506
|
| 81 |
Brian K. Chung, Eva Kristine Klemsdal Henriksen, Kristin Kaasen Jørgensen, Tom H. Karlsen, Gideon M. Hirschfield, Evaggelia Liaskou. Gut and Liver B Cells of Common Clonal Origin in Primary Sclerosing Cholangitis–Inflammatory Bowel Disease. Hepatology Communications 2018; 2(8) doi: 10.1002/hep4.1200
|
| 82 |
Hyeok Choi, Yong-Beom Park, Jaewoo Song, Sang-Won Lee. Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis. Zeitschrift für Rheumatologie 2022; 81(8) doi: 10.1007/s00393-021-00998-1
|
| 83 |
Senka Dobric, Dragan Popovic, Milos Nikolic, Sladjana Andrejevic, Milan Spuran, Branka Bonaci-Nikolic. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis. Clinical Chemistry and Laboratory Medicine 2012; 50(3) doi: 10.1515/cclm.2011.797
|
| 84 |
Simona Marzorati, Pietro Invernizzi, Ana Lleo. Making Sense of Autoantibodies in Cholestatic Liver Diseases. Clinics in Liver Disease 2016; 20(1) doi: 10.1016/j.cld.2015.08.003
|
| 85 |
Albert Parés. Colangitis esclerosante primaria: diagnóstico, pronóstico y tratamiento. Gastroenterología y Hepatología 2011; 34(1) doi: 10.1016/j.gastrohep.2010.02.006
|
| 86 |
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 2018; 38(5) doi: 10.1007/s00296-018-4021-5
|
| 87 |
Tom H. Karlsen, Kirsten Muri Boberg, Erik Schrumpf. Zakim and Boyer's Hepatology. 2012; doi: 10.1016/B978-1-4377-0881-3.00042-5
|
| 88 |
Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist, Mark Deneau, Lisa Forman, Sumera I. Ilyas, Keri E. Lunsford, Mercedes Martinez, Gonzalo Sapisochin, Rachna Shroff, James H. Tabibian, David N. Assis. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77(2) doi: 10.1002/hep.32771
|
| 89 |
Tom Hemming Karlsen, Gideon M. Hirschfield. Primary Sclerosing Cholangitis. 2017; doi: 10.1007/978-3-319-40908-5_8
|
| 90 |
Hanh D. Vo, Jiliu Xu, Simon S. Rabinowitz, Stanley E. Fisher, Steven M. Schwarz. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(3) doi: 10.1097/MPG.0000000000000444
|
| 91 |
Alexander Zipprich. Rheumatologie und Hepatologie: Diagnostik und Therapie von
autoimmunen Lebererkrankungen. Aktuelle Rheumatologie 2021; 46(05) doi: 10.1055/a-0885-9314
|
| 92 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Liver Immunology. 2020; doi: 10.1007/978-3-030-51709-0_4
|
| 93 |
Michal Prokopič, Ulrich Beuers. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatology International 2021; 15(1) doi: 10.1007/s12072-020-10118-x
|
| 94 |
Ban‐Hock Toh. Diagnostic autoantibodies for autoimmune liver diseases. Clinical & Translational Immunology 2017; 6(5) doi: 10.1038/cti.2017.14
|
| 95 |
Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Digestive and Liver Disease 2017; 49(9) doi: 10.1016/j.dld.2017.06.010
|
| 96 |
Haruka Okada, Shinya Sugimoto, Atsuto Kayashima, Yohei Mikami, Takanori Kanai, Nobuhiro Nakamoto, Yusuke Yoshimatsu, Hiroki Kiyohara, Yukie Nakadai, Ryosuke Kasuga, Nobuhito Taniki, Keisuke Ojiro, Shingo Usui, Shogo Sunaga, Ichiro Mizushima, Yuta Kaieda, Shohei Suzuki, Takaya Tabuchi, Makoto Ueno. Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease. Journal of Gastroenterology 2026; 61(7) doi: 10.1007/s00535-026-02388-3
|
| 97 |
Verghese George, Varaha Sairam Tammisetti, Venkateswar Rao Surabhi, Alampady K. Shanbhogue. Chronic Fibrosing Conditions in Abdominal Imaging. RadioGraphics 2013; 33(4) doi: 10.1148/rg.334125081
|
| 98 |
Henrike Lenzen, Tobias J. Weismüller, Ahmed A. Negm, Jenny Wlecke, Stephanie Loges, Christian P. Strassburg, Michael P. Manns, Tim O. Lankisch. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 2013; 48(10) doi: 10.3109/00365521.2013.825313
|
| 99 |
E V Vinnitskaya, S R Abdulkhakov, D T Abdurakhmanov, R B Alikhanov, I G Bakulin, E A Belousova, A O Bueverov, E Z Burnevitch, M G Efanov, E Yu Eremina, T M Ignatova, L Yu Ilchenko, G G Karmazanovsky, O V Knyazev, Yu V Kulezneva, T N Lopatkina, T P Nekrasova, I G Nikitin, V V Pavlenko, A I Parfenov, S D Podymova, K L Raichelson, A R Reisis, R G Sayfutdinov, E V Skazyvaeva, V E Syutkin, S G Khomeriki, T Yu Haimenova, Yu G Sandler. Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018). Terapevticheskii arkhiv 2019; 91(2) doi: 10.26442/00403660.2019.02.000075
|
| 100 |
Umer Malik, Bilal Ashraf, Sonia B. Samuel, Stephen Hasak. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025; doi: 10.1007/978-3-032-07868-1_12
|
| 101 |
Sina Fuchs, Monika Bayer, Richard Taubert, Michael P. Manns, Josef M. Pfeilschifter, Urs Christen, Edith Hintermann. Effects of adenovirus‐induced hepatocyte damage on chronic bile duct inflammation in a sclerosing cholangitis mouse model. Liver International 2019; 39(12) doi: 10.1111/liv.14183
|
| 102 |
Karam Karam, Johny Salem, Sarah Jalloul, Lynn Daoud, Pierre Hani. An occult primary sclerosing cholangitis unmasked by cholangiography: A case report. Medical Reports 2025; 9 doi: 10.1016/j.hmedic.2025.100168
|
| 103 |
Kazuhito Kawata, Yoshimasa Kobayashi, M. Eric Gershwin, Christopher L. Bowlus. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 2012; 43(3) doi: 10.1007/s12016-012-8324-0
|
| 104 |
John E. Eaton, Jayant A. Talwalkar, Keith D. Lindor. The Autoimmune Diseases. 2014; doi: 10.1016/B978-0-12-384929-8.00063-0
|
| 105 |
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis. Gut 2017; 66(1) doi: 10.1136/gutjnl-2016-311739
|
| 106 |
Claudia O. Zein, Keith D. Lindor. Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Current Gastroenterology Reports 2010; 12(1) doi: 10.1007/s11894-009-0079-2
|
| 107 |
Roopa Hebbandi Nanjundappa, Kun Shao, Prasanna Krishnamurthy, M. Eric Gershwin, Patrick S.C. Leung, Channakeshava Sokke Umeshappa. Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications. Autoimmunity Reviews 2024; 23(2) doi: 10.1016/j.autrev.2023.103485
|
| 108 |
Erik von Seth, Tom H Karlsen, Atsushi Tanaka, Cyriel Ponsioen, Annika Bergquist. Primary sclerosing cholangitis. The Lancet 2026; 407(10538) doi: 10.1016/S0140-6736(25)02582-6
|
| 109 |
Joyce J B C van Beers, Ger H Koek, Jan G M C Damoiseaux. The Role of Autoantibodies in the Diagnosis of Autoimmune Liver Disease: Lessons Learned from Clinical Practice. The Journal of Applied Laboratory Medicine 2022; 7(1) doi: 10.1093/jalm/jfab099
|
| 110 |
Guilherme Grossi Lopes Cançado, Gideon M. Hirschfield. Management of primary sclerosing cholangitis: Current state-of-the-art. Hepatology Communications 2024; 8(12) doi: 10.1097/HC9.0000000000000590
|
| 111 |
|
| 112 |
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
|
| 113 |
Tamsin Cargill, Emma L. Culver. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661196
|
| 114 |
Marcial Sebode, Lisa Schulz, Ansgar Lohse. “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. International Journal of Molecular Sciences 2017; 18(9) doi: 10.3390/ijms18091954
|
| 115 |
Janet Martin, Eleonora Petryayeva, Waliul I Khan. Autoantibodies in Common Connective Tissue Diseases: A Primer for Laboratory Professionals. The Journal of Applied Laboratory Medicine 2022; 7(1) doi: 10.1093/jalm/jfab131
|
| 116 |
Xiaojun Jiang, Tom H. Karlsen. Genetics of primary sclerosing cholangitis and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 2017; 14(5) doi: 10.1038/nrgastro.2016.154
|
| 117 |
. 2020; doi: 10.70675/0fdedffez92dfz4dc3zbe4ez9fdf1fa28a26
|
| 118 |
Benedetta Terziroli Beretta‐Piccoli, Giorgina Mieli‐Vergani, Diego Vergani. Autoimmune Liver Disease. 2020; doi: 10.1002/9781119532637.ch4
|
| 119 |
Bishoi Aziz, Beverley Kok, Matthew Cheah, Ellina Lytvyak, Carlos Moctezuma-Velazquez, Shawn Wasilenko, Emmanuel Tsochatzis, Reena Ravikumar, Sophie Jose, Michael Allison, Bridget Gunson, Derek Manas, Andrea Monaco, Darius Mirza, Giuseppe Fusai, Nicola Owen, Douglas Thorburn, Keith Roberts, Parthi Srinivasan, Stephen Wigmore, Anuja Athale, Felicity Creamer, Bimbi Fernando, Vikram Iyer, Mansoor Madanur, Gourab Sen, Aldo J. Montano-Loza, Bettina Hansen, Andrew L. Mason. Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. American Journal of Gastroenterology 2025; 120(2) doi: 10.14309/ajg.0000000000002977
|
| 120 |
Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio. The role of natural killer cells in autoimmune liver disease: A comprehensive review. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.07.003
|
| 121 |
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 2023; 55(7) doi: 10.1038/s12276-023-01042-9
|
| 122 |
|
| 123 |
Shikib Mostamand, Shauna Schroeder, Jacqueline Schenkein, Tamir Miloh. Infliximab‐Associated Immunomediated Hepatitis in Children With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition 2016; 63(1) doi: 10.1097/MPG.0000000000001137
|
| 124 |
Abin Chandrakumar, Rachael Loeppky, Mark Deneau, Wael El-Matary. Inflammatory Bowel Disease in Children with Elevated Serum Gamma Glutamyltransferase Levels. The Journal of Pediatrics 2019; 215 doi: 10.1016/j.jpeds.2019.07.065
|
| 125 |
Andrzej Chruscinski, Stephen Juvet, Sajad Moshkelgosha, Eberhard Renner, Leslie Lilly, Nazia Selzner, Christopher Bredeson, David Grant, Oyedele Adeyi, Sandra Fischer, Anthony J. Demetris, Jianhua Zhang, Maor Epstein, Meaghan Macarthur, Anne Marie Clement, Korosh Khalili, David Allan, Sultan Altouri, Isabelle Bence-Bruckler, Mark Cattral, Jill Fulcher, Zita Galvin, Anand Ghanekar, Paul Greig, Lothar Huebsch, Atul Humar, Andrea Kew, Natasha Kekre, Tae Kyoung Kim, Sheryl McDiarmid, Lisa Martin, Ian McGilvray, Mitchell Sabloff, Gonzalo Sapisochin, Markus Selzner, Robert Smith, Kathryn Tinckam, Tae Joon Yi, Gary Levy, Harold Atkins. Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study. Transplantation 2022; 106(3) doi: 10.1097/TP.0000000000003829
|
| 126 |
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Clinical significance of autoantibodies in autoimmune hepatitis. Journal of Autoimmunity 2013; 46 doi: 10.1016/j.jaut.2013.08.001
|
| 127 |
Erik Schrumpf, Kirsten Muri Boberg, Tom H. Karlsen. Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 2015; 50(6) doi: 10.3109/00365521.2015.1028996
|
| 128 |
Channakeshava Sokke Umeshappa, Santiswarup Singha, Jesus Blanco, Kun Shao, Roopa Hebbandi Nanjundappa, Jun Yamanouchi, Albert Parés, Pau Serra, Yang Yang, Pere Santamaria. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09893-5
|
| 129 |
Laura Räisänen, Fariha Balouch, Claire Reilly, Christopher Burgess, Peter Lewindon. Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis. British Journal of Clinical Pharmacology 2025; doi: 10.1002/bcp.70121
|
| 130 |
C. Buffet. Cholangites sclérosantes. EMC - Hépatologie 2011; 26(1) doi: 10.1016/S1155-1976(11)50375-4
|
| 131 |
Johannes R Hov, Øyvind Molberg, Tom H Karlsen. Tubulin beta 5 is not the target of antineutrophil antibodies in primary sclerosing cholangitis. Clinical and Experimental Immunology 2024; 218(1) doi: 10.1093/cei/uxae053
|
| 132 |
Laura Räisänen, Fariha Balouch, Annette McLaren-Kennedy, Julia Elizabeth Clark, Peter Lewindon. Outcomes of oral vancomycin therapy in children with atypical ulcerative colitis with or without confirmed primary sclerosing cholangitis: a real-world observational study. BMJ Open Gastroenterology 2025; 12(1) doi: 10.1136/bmjgast-2024-001605
|
| 133 |
Niv Zmora, Lian Bannon, Roie Tzadok, Noy Nachmias, Haim Leibovitzh, Ehud Zigmond. Serum Anti-Saccharomyces cerevisiae Antibody Is Associated with Disease Severity in Patients with Primary Sclerosing Cholangitis. Digestive Diseases 2026; 44(3) doi: 10.1159/000552341
|
| 134 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Serology in autoimmune hepatitis: A clinical-practice approach. European Journal of Internal Medicine 2018; 48 doi: 10.1016/j.ejim.2017.10.006
|
| 135 |
Piotr Milkiewicz, Marcin Krawczyk, Ewa Wunsch, Cyriel Ponsioen, Gideon M. Hirschfield, Stefan G. Hubscher. Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management. Hepatology Communications 2020; 4(3) doi: 10.1002/hep4.1467
|
| 136 |
Bilal Ashraf, Dana Gornick, Wajeed Sumbal, Zainab Saeed, Ruben Peredo, Micheal Tadros. GI Diseases Associated with Rheumatological and Vasculitic Conditions. Clinical Gastroenterology 2025; doi: 10.1007/978-3-032-07868-1_10
|
| 137 |
Yangfan Chen, Ruofei Chen, Haiyan Li, Zongwen Shuai. Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-025-09622-9
|
| 138 |
Maria Concetta Sorrentino, Danilo Villalta, Teresa Carbone, Maria Grazia Alessio, Maria Infantino, Luigi Cinquanta, Gaia Deleonardi, Stefan Platzgummer, Maria Teresa Trevisan, Giampaola Pesce, Brunetta Porcelli, Marilina Tampoia, Antonio Antico, Ignazio Brusca, Nicola Bizzaro. Italian Society of Clinical Pathology and Laboratory Medicine (SIPMeL) guidelines on the use of autoantibody tests in the diagnosis of autoimmune liver diseases. Autoimmunity Reviews 2026; 25(7) doi: 10.1016/j.autrev.2026.104093
|
| 139 |
Nathalie Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri. PSC and Overlap Syndromes. Current Hepatology Reports 2020; 19(2) doi: 10.1007/s11901-020-00518-w
|
| 140 |
Wenhui Zeng, Jiabing Wang, Yan Xu, Shuzhou Wu, Cixiang Chen, Shanrong Zhang, Bingli Hu, Junsong Ye. Ferroptosis regulatory networks and precision interventions in autoimmune hepatitis: comparison with cholestatic diseases. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1874855
|
| 141 |
Jason B. Samarasena, Ke-Qin Hu. Hepatobiliary Manifestations of Gastrointestinal and Nutritional Disorders. Clinics in Liver Disease 2011; 15(1) doi: 10.1016/j.cld.2010.09.003
|
| 142 |
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6) doi: 10.1111/j.1365-2036.2012.05223.x
|
| 143 |
Roger Chapman, Johan Fevery, Anthony Kalloo, David M. Nagorney, Kirsten Muri Boberg, Benjamin Shneider, Gregory J. Gores. Diagnosis and Management of Primary Sclerosing Cholangitis. Hepatology 2010; 51(2) doi: 10.1002/hep.23294
|
| 144 |
Samar H. Ibrahim, Keith D. Lindor. Current Management of Primary Sclerosing Cholangitis in Pediatric Patients. Pediatric Drugs 2011; 13(2) doi: 10.2165/11586500-000000000-00000
|
| 145 |
Elisabeth Krones, Ivo Graziadei, Michael Trauner, Peter Fickert. Evolving concepts in primary sclerosing cholangitis. Liver International 2012; 32(3) doi: 10.1111/j.1478-3231.2011.02607.x
|
| 146 |
Nora Cazzagon, Samantha Sarcognato, Elisa Catanzaro, Emanuela Bonaiuto, Matteo Peviani, Francesco Pezzato, Raffaella Motta. Primary Sclerosing Cholangitis: Diagnostic Criteria. Tomography 2024; 10(1) doi: 10.3390/tomography10010005
|
| 147 |
Tom H. Karlsen, Erik Schrumpf, Kirsten M. Boberg. Update on primary sclerosing cholangitis. Digestive and Liver Disease 2010; 42(6) doi: 10.1016/j.dld.2010.01.011
|
| 148 |
Krisztina Hagymási, Zsolt Tulassay. Review of overlap syndromes of autoimmune liver diseases. Difficulties in the diagnosis and treatment. Orvosi Hetilap 2013; 154(24) doi: 10.1556/OH.2013.29640
|
| 149 |
Klaus Felix, Oliver Hauck, Martina Schnölzer, Tore Kempf, Uwe Warnken, Kathrin Schneider, Frank Bergmann, Stefan Fritz, Jens Werner. Identification of Novel Serum Autoantibodies for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Ductal Adenocarcinoma. Pancreas 2016; 45(9) doi: 10.1097/MPA.0000000000000647
|
| 150 |
Tom Hemming Karlsen, Kirsten Muri Boberg. Sherlock's Diseases of the Liver and Biliary System. 2018; doi: 10.1002/9781119237662.ch18
|
| 151 |
|
| 152 |
Stella Gabeta, George N. Dalekos, Nikolaos K. Gatselis. Management of asymptomatic patients with abnormal liver function tests. European Journal of Internal Medicine 2025; 141 doi: 10.1016/j.ejim.2025.07.025
|
| 153 |
Naomi Richardson, Sky T. H. Ng, David C. Wraith. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01586
|
| 154 |
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3) doi: 10.1016/j.jhep.2022.05.011
|